Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM) GlobeNewswire October 06, 2025 Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application for Iopofosine I 131 as […]

Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives GlobeNewswire October 06, 2025 NEWTOWN, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) — Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory

GXO Schedules Third Quarter 2025 Earnings Conference Call for Wednesday, November 5, 2025 GlobeNewswire October 06, 2025 GREENWICH, Conn., Oct. 06, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO) will hold its third quarter 2025 earnings conference call and webcast on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time. The company's results will

USA Pickleball Grants Official Approval and Certification for J-Star's First In-House Pickleball Paddle, Horizon GlobeNewswire October 06, 2025 TAICHUNG CITY, Taiwan, Oct. 06, 2025 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal

Gogo announces first Gogo Galileo FDX STC as ALOFT AeroArchitects receives approval covering Boeing Business Jet BBJ737-series aircraft. The first Supplemental Type Certificate (STC) for the Gogo Galileo FDX terminal has been issued by the Federal Aviation Administration (FAA). GlobeNewswire October 06, 2025 Broomfield, CO., Oct. 06, 2025 (GLOBE NEWSWIRE) — Gogo (NASDAQ: GOGO) is

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Due Diligence GlobeNewswire October 06, 2025 CALGARY, Alberta, Oct. 06, 2025 (GLOBE NEWSWIRE) — Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) (“Bocana” or the “Company“), further to the press release dated August 11, 2025, August 18, 2025, and September 4, 2025, and

Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study GlobeNewswire October 06, 2025 Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the AAO-HNS 2025 Annual Meeting WATERTOWN, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE)

OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics GlobeNewswire October 06, 2025 DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's iRWD(TM)

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programs GlobeNewswire October 06, 2025 Exclusive collaboration and license agreement for the development and global commercialization of Arbor's clinical-stage gene editing program, ABO-101 for primary hyperoxaluria type 1 (PH1) Multitarget research collaboration and option agreement for Arbor's innovative

Mercury Systems and Nightwing Collaborate to Enhance Cybersecurity for Aerospace and Defense Systems GlobeNewswire October 06, 2025 ANDOVER, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, and Nightwing, the cyber and national security solutions company defining the edge of